Immediate Impact
63 standout
Citing Papers
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Applications of SGLT2 inhibitors beyond glycaemic control
2024 Standout
Works of Agnes Bosch being referenced
Effects of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function in Patients with Chronic Heart Failure
2021
SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Agnes Bosch | 205 | 286 | 70 | 144 | 44 | 543 | |
| Dennis Kannenkeril | 232 | 301 | 53 | 170 | 55 | 643 | |
| Kristina Striepe | 186 | 353 | 46 | 149 | 32 | 522 | |
| Ioanna Zografou | 123 | 313 | 24 | 128 | 35 | 618 | |
| CONNIE S. McCAA | 147 | 246 | 58 | 36 | 27 | 536 | |
| Eva Ebbehøj | 374 | 146 | 28 | 111 | 33 | 589 | |
| Chardpraorn Ngarmukos | 112 | 259 | 26 | 79 | 23 | 531 | |
| Kaifeng Guo | 141 | 157 | 47 | 46 | 36 | 567 | |
| Κ Katogiannis | 246 | 134 | 45 | 92 | 56 | 573 | |
| D. Gordon | 182 | 190 | 19 | 68 | 24 | 610 | |
| Maria Fitzgibbon | 150 | 176 | 42 | 133 | 35 | 615 |
All Works
Login with ORCID to disown or claim papers
Loading papers...